What's Happening?
Cigna has announced coverage for Cleerly's AI-based cardiovascular imaging technology, Cleerly LABS Advanced Plaque Analysis, starting October 1, 2025. This decision follows similar moves by other major insurers, recognizing the clinical and economic value of AI-enabled coronary tomography and plaque analysis. The coverage will apply to patients meeting specific clinical criteria, enhancing precision medicine in cardiology.
Why It's Important?
Cigna's coverage of Cleerly's AI-based imaging technology marks a significant shift in cardiovascular care, emphasizing the role of precision medicine in improving patient outcomes. By adopting advanced plaque analysis, insurers are supporting more informed clinical decisions, potentially reducing healthcare costs and improving treatment efficacy. This move reflects broader trends in healthcare towards integrating AI and data-driven insights into patient care.
What's Next?
With Cigna's coverage, Cleerly's technology is now accessible to over 61 million Americans, including those covered by Medicare and other insurers. As AI-QCT/AI-CPA technology gains traction, further adoption by healthcare providers and insurers is expected, potentially leading to widespread changes in cardiovascular diagnostics and treatment strategies. The upcoming CPT I code in January 2026 will further facilitate integration into clinical practice.
